Description: The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Home Page: www.biotechgt.com/index.php/biog/home/over
BIOG Technical Analysis
601 Lexington Avenue
New York,
NY
10022
United States
Phone:
212-739-6400
Officers
| Name | Title |
|---|---|
| Mr. Samuel David Isaly | Portfolio Mang. |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8456 |
| Price-to-Sales TTM: | 2.1821 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |